These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

609 related items for PubMed ID: 19450936

  • 1. Helicobacter pylori heat shock protein 60 antibodies are associated with gastric cancer.
    Tanaka A, Kamada T, Yokota K, Shiotani A, Hata J, Oguma K, Haruma K.
    Pathol Res Pract; 2009; 205(10):690-4. PubMed ID: 19450936
    [Abstract] [Full Text] [Related]

  • 2. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
    Konturek PC, Konturek SJ, Bielanski W, Karczewska E, Pierzchalski P, Duda A, Starzynska T, Marlicz K, Popiela T, Hartwich A, Hahn EG.
    J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
    [Abstract] [Full Text] [Related]

  • 3. Helicobacter pylori antibodies and gastric cancer: a gender-related difference.
    Janulaityte-Günther D, Kupcinskas L, Pavilonis A, Valuckas K, Percival Andersen L, Wadström T.
    FEMS Immunol Med Microbiol; 2005 May 01; 44(2):191-5. PubMed ID: 15866215
    [Abstract] [Full Text] [Related]

  • 4. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease.
    Schumann C, Triantafilou K, Rasche FM, Möricke A, Vogt K, Triantafilou M, Hahn P, Schneider EM, Lepper PM.
    Int J Med Microbiol; 2006 Aug 01; 296(4-5):223-8. PubMed ID: 16600680
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Presence of antibodies against Helicobacter pylori and its heat-shock protein 60 in the serum of patients with Sjögren's syndrome.
    Aragona P, Magazzù G, Macchia G, Bartolone S, Di Pasquale G, Vitali C, Ferreri G.
    J Rheumatol; 1999 Jun 01; 26(6):1306-11. PubMed ID: 10381048
    [Abstract] [Full Text] [Related]

  • 7. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
    Camorlinga-Ponce M, Flores-Luna L, Lazcano-Ponce E, Herrero R, Bernal-Sahagún F, Abdo-Francis JM, Aguirre-García J, Muñoz N, Torres J.
    Cancer Epidemiol Biomarkers Prev; 2008 Sep 01; 17(9):2498-504. PubMed ID: 18768521
    [Abstract] [Full Text] [Related]

  • 8. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
    Vorobjova T, Ren Z, Dunkley M, Clancy R, Maaroos HI, Labotkin R, Kull K, Uibo R.
    APMIS; 2006 May 01; 114(5):372-80. PubMed ID: 16725014
    [Abstract] [Full Text] [Related]

  • 9. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases.
    Chomvarin C, Ottiwet O, Hahnvajanawong C, Intapan PM, Wongwajana S.
    Int J Infect Dis; 2009 Sep 01; 13(5):647-54. PubMed ID: 19233700
    [Abstract] [Full Text] [Related]

  • 10. Serum antibodies to Helicobacter pylori and its heat-shock protein 60 correlate with the response of gastric mucosa-associated lymphoid tissue lymphoma to eradication of H. pylori.
    Takenaka R, Yokota K, Mizuno M, Okada H, Toyokawa T, Yamasaki R, Yoshino T, Sugiyama T, Asaka M, Shiratori Y, Oguma K.
    Helicobacter; 2004 Jun 01; 9(3):194-200. PubMed ID: 15165254
    [Abstract] [Full Text] [Related]

  • 11. Immunoproteomics of Helicobacter pylori infection in patients with atrophic body gastritis, a predisposing condition for gastric cancer.
    Lahner E, Bernardini G, Possenti S, Renzone G, Scaloni A, Santucci A, Annibale B.
    Int J Med Microbiol; 2011 Feb 01; 301(2):125-32. PubMed ID: 20843738
    [Abstract] [Full Text] [Related]

  • 12. Differential features of gastric cancer patients, either Helicobacter pylori positive or Helicobacter pylori negative.
    Jonkers D, Houben P, Hameeteman W, Stobberingh E, de Bruine A, Arends JW, Biemond I, Lundqvist G, Stockbrügger R.
    Ital J Gastroenterol Hepatol; 1999 Dec 01; 31(9):836-41. PubMed ID: 10669990
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The interrelationship between Helicobacter pylori vacuolating cytotoxin and gastric carcinoma.
    de Figueiredo Soares T, de Magalhães Queiroz DM, Mendes EN, Rocha GA, Rocha Oliveira AM, Alvares Cabral MM, de Oliveira CA.
    Am J Gastroenterol; 1998 Oct 01; 93(10):1841-7. PubMed ID: 9772042
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Helicobacter pylori-positive patients with pruritic skin diseases are at increased risk for gastric cancer.
    Shiotani A, Sakurane M, Furukawa F.
    Aliment Pharmacol Ther; 2004 Jul 01; 20 Suppl 1():80-4. PubMed ID: 15298610
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Is the association between Helicobacter pylori and gastric cancer confined to CagA-positive strains?
    Held M, Engstrand L, Hansson LE, Bergström R, Wadström T, Nyrén O.
    Helicobacter; 2004 Jun 01; 9(3):271-7. PubMed ID: 15165264
    [Abstract] [Full Text] [Related]

  • 20. Helicobacter pylori in gastric cancer in India.
    Bhasin DK, Kakkar N, Sharma BC, Joshi K, Sachdev A, Vaiphei K, Singh K.
    Trop Gastroenterol; 1999 Jun 01; 20(2):70-2. PubMed ID: 10484891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.